Trials / Completed
CompletedNCT01571557
A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 573 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the relationship between time since onset of macular oedema symptoms and the achievement of vision gain in patients prescribed OZURDEX®. All care and diagnostic procedures provided are at the discretion of the participating physicians according to their clinical judgment and local standard of medical care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone 700 ug intravitreal implant | dexamethasone 700 ug intravitreal implant administered according to standard of care. |
Timeline
- Start date
- 2012-04-30
- Primary completion
- 2014-03-31
- Completion
- 2014-06-30
- First posted
- 2012-04-05
- Last updated
- 2019-04-19
- Results posted
- 2015-07-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01571557. Inclusion in this directory is not an endorsement.